Top Markets
#1 OSK OSK +15.26%
#2 Nesa Nesa +8.15%
#3 UnifAI Network UnifAI Network +7.36%
#4 HOME HOME +7.04%
#5 Tornado Cash Tornado Cash +6.57%
#6 TENDIES TENDIES +5.13%
#7 Bitway Bitway +4.69%
#8 Biconomy Biconomy +4.21%
#9 Prom Prom +3.56%
#10 Big Time Big Time +3.37%
Coin of the day
OSK OSK
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Classement en actions #16436
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Prix de l'action
$4.64
Dernière synchronisation: 2022-09-12
Capitalisation boursière
$293.43M
Changement (1 jour)
0.87%
Changement (1 an)
0.00%
Pays
US
Échange Adagio Therapeutics, Inc. (ADGI)

Catégorie

Healthcare
Ratio P/S pour Adagio Therapeutics, Inc. (ADGI)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Adagio Therapeutics, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Adagio Therapeutics, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.95 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.19 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
24.99 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.75 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH